4526700272|Procurement under the Framework Agreement, for the supply of Cardiovascular System Medications - CP 2025/1627 - SPMS

This tender, identified by reference number 4526700272, concerns the procurement of medications for the cardiovascular system. Similar to tender ID 14, this acquisition is being made under a pre-existing Framework Agreement (CP 2025/1627) facilitated by SPMS (Serviços Partilhados do Ministério da Saúde - Shared Services of the Ministry of Health). This framework agreement streamlines the process for acquiring essential medicines by having pre-negotiated terms and conditions. The specific focus remains on pharmaceuticals required for treating conditions affecting the heart and blood vessels. SPMS plays a crucial role in centralizing public health procurement in Portugal, aiming for better pricing and supply chain management. Bidders are expected to be authorized pharmaceutical companies capable of supplying the specified cardiovascular drugs according to the framework agreement's stipulations. The tender documents will detail the required medications, quantities, packaging standards, delivery logistics, and adherence to all relevant pharmaceutical regulations. The primary goal is to ensure the continuous availability of necessary cardiovascular medications for the national health service in an efficient and economical manner.

This is a supplies contract in the health and medical services, transport and logistics and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 287.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.